Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Psycho-Oncology
|
January 13, 2025
Stress Management Program for Scanxiety in People With Advanced Lung Cancer: Intervention Adaptation and Stakeholder Feedback
Heather Derry-Vick, Amanda Khoudary, Osairys Billini, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
April 19, 2011
Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation
Vera Bril, John England, Gary M Franklin, et al.
Journal of the American Academy of Dermatology
|
June 5, 2019
Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials
Lourdes Maria Perez-Chada, Alice Bendix Gottlieb, Jeffrey Cohen, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2004
Novel pyrrole-containing progesterone receptor modulators
Mark A Collins, Valerie Hudak, Reinhold Bender, et al.
Bioorganic & Medicinal Chemistry
|
August 8, 2007
5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist
Puwen Zhang, Eugene Terefenko, Jeffrey Kern, et al.
Bioorganic & Medicinal Chemistry
|
May 28, 2008
7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists
Puwen Zhang, Jeffrey C Kern, Eugene A Terefenko, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
September 4, 2019
Utility of motor evoked potentials to diagnose and reduce lower extremity motor nerve root injuries during 4,386 extradural posterior lumbosacral spine procedures
W Bryan Wilent, Eric A Tesdahl, James S Harrop, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2002
New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles
Andrew Fensome, Reinhold Bender, Jeffrey Cohen, et al.
American Journal of Medical Genetics. Part A
|
September 9, 2016
Clinicians' experiences with the fragile X clinical and research consortium
Jessica A Liu, Randi J Hagerman, Robert M Miller, et al.
Journal of Neurointerventional Surgery
|
January 14, 2021
Intraoperative vascular complications during 2278 cerebral endovascular procedures with multimodality IONM: relationship between signal change, complication, intervention and postoperative outcome
W Bryan Wilent, Olga Belyakina, Eric Korsgaard, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Psycho-Oncology
|
January 13, 2025
Stress Management Program for Scanxiety in People With Advanced Lung Cancer: Intervention Adaptation and Stakeholder Feedback
Heather Derry-Vick, Amanda Khoudary, Osairys Billini, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
April 19, 2011
Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation
Vera Bril, John England, Gary M Franklin, et al.
Journal of the American Academy of Dermatology
|
June 5, 2019
Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials
Lourdes Maria Perez-Chada, Alice Bendix Gottlieb, Jeffrey Cohen, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2004
Novel pyrrole-containing progesterone receptor modulators
Mark A Collins, Valerie Hudak, Reinhold Bender, et al.
Bioorganic & Medicinal Chemistry
|
August 8, 2007
5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist
Puwen Zhang, Eugene Terefenko, Jeffrey Kern, et al.
Bioorganic & Medicinal Chemistry
|
May 28, 2008
7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists
Puwen Zhang, Jeffrey C Kern, Eugene A Terefenko, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
September 4, 2019
Utility of motor evoked potentials to diagnose and reduce lower extremity motor nerve root injuries during 4,386 extradural posterior lumbosacral spine procedures
W Bryan Wilent, Eric A Tesdahl, James S Harrop, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2002
New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles
Andrew Fensome, Reinhold Bender, Jeffrey Cohen, et al.
American Journal of Medical Genetics. Part A
|
September 9, 2016
Clinicians' experiences with the fragile X clinical and research consortium
Jessica A Liu, Randi J Hagerman, Robert M Miller, et al.
Journal of Neurointerventional Surgery
|
January 14, 2021
Intraoperative vascular complications during 2278 cerebral endovascular procedures with multimodality IONM: relationship between signal change, complication, intervention and postoperative outcome
W Bryan Wilent, Olga Belyakina, Eric Korsgaard, et al.
Page
of 12